Two Sigma Advisers’s Alignment Healthcare ALHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-140,700
Closed -$2.78M 81
2025
Q4
$2.78M Sell
140,700
-694,100
-83% -$12.5M 0.01% 1057
2025
Q3
$14.6M Buy
834,800
+738,600
+768% +$11M 0.03% 402
2025
Q2
$1.35M Buy
96,200
+54,384
+130% +$876K ﹤0.01% 1304
2025
Q1
$779K Buy
41,816
+3,016
+8% +$45K ﹤0.01% 1581
2024
Q4
$437K Buy
+38,800
New +$454K ﹤0.01% 1830
2023
Q3
Sell
-18,300
Closed -$105K 2373
2023
Q2
$105K Sell
18,300
-224,600
-92% -$1.45M ﹤0.01% 2205
2023
Q1
$1.54M Sell
242,900
-800
-0.3% -$7.63K ﹤0.01% 1409
2022
Q4
$2.87M Buy
243,700
+222,800
+1,066% +$2.71M 0.01% 1040
2022
Q3
$247K Buy
+20,900
New +$305K ﹤0.01% 2138

Other funds holding ALHC

Two Sigma Advisers's ALHC Position: Q1 2026 in Review

Two Sigma Advisers sold out of Alignment Healthcare (ALHC) in Q1 2026, closing a stake of 140,700 shares — an estimated $2.78M sold.

Two Sigma Advisers first reported a position in ALHC in Q3 2022 and held it in 9 quarters. The position peaked at $14.6M in Q3 2025. 293 funds tracked by Wall St. Rank hold ALHC as of Q1 2026.

  • Two Sigma Advisers reported no remaining Alignment Healthcare position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 140,700 Alignment Healthcare shares in Q1 2026, an estimated $2.78M.
  • Two Sigma Advisers first reported a position in Alignment Healthcare in Q3 2022 and held it in 9 quarters.
  • Two Sigma Advisers's Alignment Healthcare position peaked at $14.6M in Q3 2025.
  • 293 funds tracked by Wall St. Rank held Alignment Healthcare as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.